NASDAQ: GWPH - GW Pharmaceuticals plc

Lønnsomhet i seks måneder: +143.26%
Utbytte: 0.00%
Sektor: Healthcare

Rapportering GW Pharmaceuticals plc

Store bokstaver

IFRS
Rapportering Årlig Kvartalsvis
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 LTM 5 års gjennomsnitt CAGR 5
Капитализация, млрд $
0.1157 0.7477 1.42 1.6 33.97 3.81 4.53 6.51 6.87 10.08 32.40
Выручка, млрд $
0.053 0.044 0.049 0.043 0.013 0.011 0.013 0.311 0.527 0.559 0.1750 109.69
Чистая прибыль, млрд $
0.004 -0.007 -0.024 -0.068 -0.083 -0.176 -0.295 -0.009 -0.058 -0.07 -0.1242 -6.92
EV, млрд $
0.0592 0.4969 1.15 1.12 33.66 3.22 4.01 6.23 6.39 9.65 40.95
EBIT, млрд $
-0.0102 -0.0228 -0.0634 -0.1073 -0.1958 -0.3363 -0.0092 -0.055 -0.1407 -12.51
EBITDA, млрд $
0 -0.1958 0 0.001 -0.04 -0.039 -0.0783 -41.10
Баланс стоимость, млрд $
0.0276 0.0343 -0.069 -0.0815 -0.1278 -0.2317 -0.4619 0.692 0.726 0.7411 0.2931 -226.18
FCF, млрд $
0.001 -0.016 -0.032 -0.098 -0.122 -0.17 -0.265 -0.166 -0.055 -0.046 -0.1556 -14.73
Операционный денежный поток, млрд $
0.0037 0.0029 -0.0075 -0.0126 -0.057 -0.1102 -0.149 -0.3014 -0.1235 -0.0274 -0.1423 -24.30
Операционная прибыль, млрд $
0.002 -0.017 -0.037 -0.096 -0.146 -0.199 -0.289 -0.118 -0.052 -0.066 -0.1608 -18.66
Операционные расходы, млрд $
0.0375 0.0529 0.092 0.1596 0.2096 0.3574 0.4026 0.5414 0.3341 27.67
CAPEX, млрд $
0.002 0.004 0.012 0.027 0.012 0.022 0.033 0.042 0.028 0.026 0.0274 18.47


Balanse

IFRS
Rapportering Årlig Kvartalsvis
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 LTM 5 års gjennomsnitt CAGR 5
Наличность, млрд $
0.0473 0.0616 0.2668 0.2879 0.4878 0.3231 0.5915 0.5369 0.49 0.4868 0.4859 0.09
Total Receivables $
0.0039 0.0067 0.000457 0.001 0.0014 0.0133 0.0489 0.0712 0.0272 134.69
Total Current Assets $
0.0474 0.1764 0.3128 0.5271 0.3646 0.6668 0.6996 0.7295 0.5975 6.72
Чистые активы, млрд $
0.0276 0.0343 0.0573 0.2572 0.3007 0.5192 0.3727 0.0824 0.1527 0.1438 0.2542 -22.65
Активы, млрд $
0.0611 0.0692 0.0954 0.3139 0.3552 0.5905 0.446 0.7739 0.8822 0.9395 0.7264 9.73
Short Term Debt $
0.002 0.000218 0.000348 0.0011 0.000471 0.000539 0.000595 0.0000 0.0006 11.32
Long Term Debt $
0.0031 0.0157 0.0151 0.0109 0.0152 0.0094 0.0092 0.0088 0.0107 -4.19
Задолженность, млрд $
0.0335 0.035 0.0381 0.0566 0.0545 0.0713 0.0733 0.082 0.1562 0.1984 0.1162 22.71
Чистый долг, млрд $
-0.0442 -0.0473 -0.0565 -0.2508 -0.2725 -0.4759 -0.3074 -0.5854 -0.5213 -0.4526 -0.4685 -1.00
Долг, млрд $
0.0051 0.016 0.0154 0.012 0.0157 0.01 0.0097 0.05 0.0436 0.0195 33.03
Interest income $
0.000207 0.000567 0.0022 0.0096 0.0085 0.0018 0.0045 25.99
Чист. проц. доходы, млрд $
0.000341 0.0012 0.0024 0.0074 0.000693 0.0024 15.24
Goodwill $
0.0081 0.0084 0.0084 0.0085 0.0064 0.0068 0.007 0.007 0.007 0.007 0.0070 0.58
Амортизация, млрд $
0.0117 0.0092 0.0128 0.0112 3.04
Себестоимость, млрд $
0.0262 0.0316 0.0386 0.0405 0.0032 0.0035 0.0047 0.0079 0.0272 0.0375 0.0162 60.69
Товарно материальные запасы $
0.0022 0.0057 0.0075 0.0077 0.0058 0.0055 0.0057 0.051 0.0855 0.1291 0.0554 87.98


Forfremmelse

IFRS
Rapportering Årlig Kvartalsvis
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2024 LTM 5 års gjennomsnitt CAGR 5
EPS -0.58 -1.36 -3.29 -4.08 -6.72 -10.56 -0.24 -1.8 -0.05 -2.16 -3.8740 -62.48
Цена акции ао 41.54 67.68 69.44 111.75 132.01 97.39 104.56 115.41 218.96 218.96 133.67 10.65
Число акций ао, млн 12 13 18 21 23 304 28 31 31 83.40 6.15
FCF/акцию 0.0649 -0.8536 -1.36 -3.77 -5.31 -0.5636 -12.45 -5.35 -1.79 -5.0927 -19.55


Effektivitet

IFRS
Rapportering Årlig Kvartalsvis
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 LTM Bransjegjennomsnitt 5 års gjennomsnitt CAGR 5
ROE, % 13.01 -16.07 -15.13 -21.46 -18.62 -39.56 -74.93 -1.29 -7.92 -9.62 29.56 -28.4640 -15.72
ROA, % 6.17 -8.94 -11.63 -17.93 -16.11 -34.04 -63.03 -1.1 -6.38 -7.81 9.53 -24.1320 -16.91
ROIC, % 12.33 -15.26 -14.88 -21.34 -18.49 -39.2 -74.63 -2.24 -7.55 -9.05 17.65 -28.4220 -16.40
ROS, % -617.13 -1598.54 -1760.81 -2.9 -11.03 -12.52 -12.52 -12.52 -12.52 -12.52 23.21 -12.2220 2.57
ROCE, % -17.87 -8.87 -21.1 -20.66 -52.53 -48.61 -1.27 -7.43 0 0 35.43 -26.1000 -18.50
Ebit margin, % 0 0
Рентаб EBITDA, % -1773.96 -1723.41 -35.07 -11.03 -6.98 -6.98 31.33 -710.0900 -66.96
Чистая рентаб, % 3.1 -38.4 -76 -222.3 -617.13 -1598.54 -1760.81 -38 -9.8 -11.7 23.20 -804.8560 -56.33
Operation Margin, % -200.53 -1087.33 -1799.36 -1783.98 -38.04 -9.82 -11.81 -11.81 -11.81 -11.81 27.09 -16.6580 -20.86
Чистая процентная маржа, % 15.13 9.28 7.52 -16.67 -48.79 -156.14 -617.13 -2.9 -11.03 -12.49 24.17 -167.1980 -25.72
Доходность FCF, % -9.59 -3.26 -5.56 -7.65 -0.5044 -9.16 -3.66 -1.6 -4.5149 -26.87


Odds

IFRS
Rapportering Årlig Kvartalsvis
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Bransjegjennomsnitt 5 års gjennomsnitt CAGR 5
P/E
-25.43 -51.28 -26.03 -19.24 -192.67 -11.14 -502.81 91.14 91.14 27.98 -126.9440 -236.49
P/BV
10.8 5.2 4.1 5.4 10 7.2 4.5 4.9 9.4 7.37 6.40 -1.92
P/S
11.9 24.3 33 188.7 303 212.8 263.2 7.4 12.3 6.93 195.02 -47.68
P/FCF
-16.71 -10.92 -27.33 -62.49 -149.35 -149.35 -149.35 -149.35 37.86 -107.5740 40.45
E/P
-0.0268 -0.0405 -0.0621 -0.0897 -0.002 -0.0168 -0.0102 -0.0102 -0.0102 -0.0102 0.04 -0.0099 38.52
EV/EBITDA
-171.95 -9.65 -36.71 -159.76 -163.78 22.92 -94.5175 -1.82
EV/EBIT
0 0 0
EV/S
50.4 116.93 229.68 166.25 12.87 5.66 11.43 11.43 11.43 11.43 7.21 10.56 -2.35
EV/FCF
-14.91 -9.25 -24.15 -53.86 -138.91 -138.91 -138.91 41.58 -73.0160 71.92
Debt/EBITDA
-0.08 -0.0298 -0.0893 -0.227 -1.12 -1.12 -1.12 -1.12 2.20 -0.7353 65.83
Netdebt/Ebitda
1.75 4.77 11.6 0 0 0 0 1.12 6.04 87.85
Debt/Ratio
0.0435 0.0203 0.0352 0.0129 0.011 0.0094 0 0 0 0 0.23 0.0178 -14.27
Debt/Equity
0.0514 0.023 0.0422 0.0144 0.0134 0.0119 0 0 0 0 2.64 0.0210 -12.35
Debt/Net Income
-0.2826 -0.1442 -0.0891 -0.0292 -1.08 -0.1523 -0.6229 -0.6229 -0.6229 -0.6229 3.19 -0.6202 -10.42
Бета
1.96 0 0 0 0 0 0 -0.29 1.96 0.00
Индекс Альтмана
3.8 5.92 4.57 0 0 0 0 0 0 -65.39 4.76 6.34


Utbytte

IFRS
Rapportering Årlig
2020 LTM Bransjegjennomsnitt 5 års gjennomsnitt CAGR 5
Дивиденды / прибыль, %
0 0 40.48


Betal for abonnementet ditt

Mer funksjonalitet og data for selskaps- og porteføljeanalyse er tilgjengelig med abonnement

Abonner